Part I Overview Information

Department of Health and Human Services

Participating Organizations
National Institutes of Health (NIH), (

Components of Participating Organizations
National Institute on Aging, (NIA), (
Office of Dietary Supplements (ODS), (

Title: Paul B. Beeson Career Development Awards in Aging (K08 & K23)

Announcement Type
This is a reissuance of RFA-AG-08-006

Update: The following update relating to this announcement has been issued:

Request For Applications (RFA) Number: RFA-AG-09-012

Catalog of Federal Domestic Assistance Number(s)

Key Dates
Release Date: July 9, 2008
Letters of Intent Receipt Date: October 3, 2008
Application Receipt Date: November 3, 2008
Peer Review Date: February-March 2009
Council Review Date: May 2009
Earliest Anticipated Start Date: July 1, 2009
Additional Information To Be Available Date (Url Activation Date): Not Applicable
Expiration Date: November 4, 2008

Due Dates for E.O. 12372

Not Applicable

Additional Overview Content

Executive Summary

Table of Contents

Part I. Overview Information

Part II. Full Text of Announcement

Section I. Funding Opportunity Description
1. Research Career Objectives

Section II. Award Information
1. Mechanism(s) of Support
2. Funds Available

Section III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2. Cost Sharing or Matching
3. Other - Special Eligibility Criteria

Section IV. Application and Submission Information
1. Address to Request Application Information
2. Content and Form of Application Submission
3. Submission Dates and Times
A. Receipt, Review and Anticipated Start Dates
1. Letter of Intent
B. Sending an Application to the NIH
C. Application Processing
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements and Information

Section V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review Considerations
C. Resource Sharing Plan(s)
3. Anticipated Announcement and Award Dates

Section VI. Award Administration Information
1. Award Notices
2. Administrative and National Policy Requirements
3. Reporting

Section VII. Agency Contact(s)
1. Scientific/Research Contact(s)
2. Peer Review Contact(s)
3. Financial/ Grants Management Contact(s)

Section VIII. Other Information - Required Federal Citations

Part II - Full Text of Announcement

Section I. Funding Opportunity Description

1. Research Career Objectives

The National Institute on Aging (NIA), and the NIH Office of Dietary Supplements (ODS), working in part with funds contributed by the John A. Hartford Foundation (, The Atlantic Philanthropies (, the Starr Foundation ( and The American Federation for Aging Research (, are pursuing this initiative to sustain and promote the research careers of clinically trained individuals who are pursuing research careers in aging.

The program is named after Dr. Paul B. Beeson who profoundly influenced the career paths of many physicians, including several who now form the core leadership in geriatric medicine. Dr. Beeson was Chairman of Medicine at Emory and Yale Medical Schools, Nuffield Professor at Oxford University and Professor and distinguished VA Physician at the University of Washington. He chaired the first Institute of Medicine study on "Aging and Medical Education" in 1978. His leadership as an editor of the Cecil Textbook of Medicine greatly influenced medical education. From his research and patient care base, he grew increasingly interested in the process of aging, and this interest led to a commitment that included his editorship of the Journal of the American Geriatrics Society. Dr. Beeson died in August 2006 at the age of 97.

The aims of the Paul B. Beeson Career Development Awards in Aging (BCDA) program are:

To encourage and assist the development of future leaders in the field of aging by supporting clinically-trained (primarily physician) faculty members early in their careers to gain additional research training and to establish independent programs in aging research.

To deepen the commitment of research institutions to academic research in aging and to translating research outcomes to geriatric medicine by involving mentor and recipient in establishing and advancing the recipient's career in aging research.

To expand clinically-relevant research on aging broadly defined to include work in the basic sciences, including animal models of aging where there is apparent clinical relevance; maintenance of health and independence in old age; diseases and disabilities of old age; and issues in the clinical management, and systems of care for the elderly.

The BDCA program now includes additional support for clinically trained scientists who wish to pursue careers dedicated to research on Alzheimer’s disease and other neurodegenerative diseases, formerly supported by the Alzheimer’s Disease Clinical Scientist Development Award announcement. Up to three additional awards each year will be dedicated to investigators planning careers in neuroscience related to aging and neurodegenerative disease.

Overall the program will foster the independent research careers of clinically trained investigators whose research will enhance the health and quality of life of Americans, particularly older people.

Research Career Objectives

The numbers of physicians and other clinically-trained individuals who are committing to and sustaining independent research careers in the biomedical sciences remain inadequate to address the opportunities for translational research, interdisciplinary collaboration, and groundbreaking basic research being generated by advances in genetics, biomedical engineering, and other life sciences. Within the field of aging research the small numbers of individuals receiving training in geriatrics, and the smaller numbers pursuing research on aging remain inadequate to address the burgeoning needs of the rapidly growing older population. The aging of the American population requires a substantial investment in current and future faculty who will devote their careers to advancing knowledge of effective prevention and management of illness and disabilities, and to inspire successive generations to do the same.

This program provides support to clinically-trained faculty members in strong research environments to enable them to gain skills and experience in clinically-relevant aging research and to establish an independent program of research in this field. If you are such a faculty member and wish to apply for this program you must identify a mentor or mentors. These individuals should be senior researchers in aging and/or geriatrics who agree to commit time to supervising and guiding you during the period of the award.


The BCDA is intended to provide you with the resources and time to establish yourself as an independent and funded investigator whose research focuses on clinically-relevant topics in aging. It is targeted primarily at individuals who have had some prior training in research coursework, methods, and resources related to aging research and who have received initial funding for research such as through Small Grant (R03) support from NIH, through similar support from other federal agencies, or through foundation funding. As a career development award it will allow you time to expand your research training and skills to permit your emergence as a leader in aging research. As such your career development plan should reflect a detailed strategy to advance your research skills that complements the research that you will be undertaking.

Junior candidates (who have not yet received initial research support) may apply where you have shown clear evidence of early leadership potential through academic honors and awards and early research accomplishment. The career development plan should be tailored to your particular career goals, your current level of experience and the environment (including mentors) in which your career development will take place. Junior candidates with limited prior research training and research experience or more senior candidates who are changing or expanding research areas will more likely need longer periods of support on the BCDA, didactic coursework, and guided research experiences than those with more research training and experience in their proposed field of study. More senior candidates who are now expanding their research efforts within their chosen field of study and transitioning to full independence should clearly state their specific career goals and how these goals will be realized through the proposed program of career development under this award. It is particularly important to show those career development activities that are essential to advance to independence, that complement the research planned, and that could not be accomplished through research support alone. Similarly it is important to show that the mentoring available through this award will clearly benefit your emergence as a leading researcher in your chosen field.

To accommodate these differences in prior experience or intended direction the initial BCDA award may be from three to five years. In addition, clinically-trained candidates with limited research experience are eligible for an up to two year renewal (formerly competing continuation) of the BCDA as described under Funds Available (Section II.2). Candidates who have a research doctorate earned prior to receiving the BCDA are not eligible for this renewal. Your program must be tailored to your individual needs and ensure that you will gain the experience, knowledge and skills necessary to carry out high quality clinically-relevant aging research. You and your mentor(s) are jointly responsible for the preparation of the plan for this program.

You must devote at least 75% (nine person-months) of your full-time professional effort to the goals of this award. You may devote the remainder to activities that are consistent with the purpose of the award and which allow you to develop the necessary experience, knowledge and skills to become an independent researcher in a clinically-relevant field of aging. The BCDA program allows support for your salary, and for research/research development expenses to be used for research and training.

The proposed training and research must focus on clinically-relevant research on aging and/or the aged. Your research project may be in the basic sciences, use animal models, or employ primary or secondary data analysis as well as clinical and patient-focused methods. The full range of research methods appropriate to completing the proposed investigation is encouraged provided that the application makes clear the clinical-relevance of the proposed work. ODS has particular interests in the roles of dietary supplements in preventing and reducing risk factors for disease and in enhancing physical and mental health and performance. ODS is also interested in research exploring the biochemical and physiological effects of supplements and in improved scientific methods for the study of dietary supplements. Research on these interests as they relate to the health and performance of older adults is particularly encouraged. The BCDA program also now includes funding for up to three additional positions formerly allocated to the NIA Alzheimer’s Disease Clinical Scientist Development Award program and therefore encourages additional applications addressing innovative approaches to neuroscience research that would have relevance to brain aging, Alzheimer’s disease and other neurodegenerative diseases.

Mentor(s): You must name a primary mentor, who together with you is responsible for the planning, direction, and execution of the program. Your mentor should be an accomplished investigator in the proposed research area and have a track record of success in training independent investigators. You may also nominate co-mentors as appropriate to the goals of the program. It is important that research expertise in the fields of aging and an appropriate funding history of support for aging research be well-represented among your mentors. Where feasible, women, minority individuals and individuals with disabilities should be involved as mentors to serve as role models.

In addition your institution must have a well-established research and clinical career development program with an emphasis or specialty in geriatrics and/or other areas of aging-related research. It must have faculty qualified in aging research to serve as mentors. Your institution must demonstrate a commitment to your development as a productive, independent investigator in aging-related research. Such commitment may be expressed in terms of the expected distribution of resources to you (for example, an independent laboratory) as you progress through the BCDA.

See Section VIII, Other Information - Required Federal Citations, for policies related to this announcement.

Section II. Award Information

1. Mechanisms of Support

This funding opportunity will use the NIH Patient-Oriented Research Career Development (K23) award mechanism (for applications pursuing patient-oriented research); and the NIH Mentored Clinical Scientist Development (K08) award mechanism (for applications that do not involve direct interaction with human participants).

As an applicant, you will be solely responsible for planning, directing, and executing the proposed project.

This funding opportunity uses the just-in-time budget concepts. It also uses the non-modular budget format described in the PHS 398 application instructions (see Follow the budget instructions described in the PHS 398 form section on research career development awards.

2. Funds Available

The National Institute on Aging, and ODS, intend to commit (in combination) approximately $1.8 million in FY 2009;

The John A. Hartford Foundation, The Atlantic Philanthropies, The Starr Foundation and the American Federation for Aging Research have agreed to contribute to this initiative by providing supplemental awards to increase the number of candidates funded and/or by making independent awards and by sponsoring an annual meeting of the funded investigators and primary mentors. NIA strongly encourages you to share your application with these foundations and to share the results of peer review with them. You may send your application to the American Federation for Aging Research (AFAR) at the address below. AFAR will share it with the other listed foundations:

American Federation for Aging Research
Attn: Paul B. Beeson Career Development Awards in Aging Program
55 West 39th Street, 16th Floor
New York, NY 10018

Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Although the financial plans of the NIA, and ODS provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications.

Some awardees may be eligible for a renewal of the Beeson award. Clinically-trained applicants with no prior NIH career development or similar award from other sources prior to the initial BCDA may seek support for one renewal of the BCDA. This renewal may not request support for more than two additional years. The two year direct costs are limited to $300,000 with no more than $200,000 allowed in any one year. However, if you possess a research doctorate you are not eligible for the two-year continuation.

The following costs are allowed within the overall amounts described above:

1. Salary: The NIA, and ODS, will provide salary and fringe benefits for you. The total salary requested must be based on a full-time, 12-month staff appointment. It must be consistent both with the established salary structure at your institution and with salaries actually provided by the institution from its own funds to other staff members of equivalent qualifications, rank, and responsibilities in the department concerned. If full-time, 12-month salaries are not currently paid to comparable staff members, the salary proposed must be appropriately related to the existing salary structure. The salary awarded may be no more than the legislative cap in effect at the time of award. Information on the current legislative limit is available at:

At least 75% (nine person-months) of full-time effort must be devoted to the goals of this award. Because the salary amount provided by this award is based on your full-time institutional salary, other PHS funds may not be used to supplement the salary. Institutional supplementation of salary must not require extra duties or responsibilities that would interfere with the purpose of the BCDA. Under expanded authorities, however, institutions may rebudget funds within the total costs awarded to cover salaries consistent with the institution's salary scale provided that the resulting salary is within the current legislative cap.

If you obtain independent research funding as one of the named principal investigators of an NIH research grant award or equivalent award from another federal agency then, in the final two years of the BCDA, the effort required on the career award may be reduced to no less than 50 percent (six person-months) and replaced by effort from the research award so that the total level of research commitment remains at 75 percent or more for the duration of the mentored career award. See: for further details about this policy.

2. Research Development Support: Examples of these expenses include: (a) tuition, and fees, related to career development; (b) research expenses, such as supplies, equipment and technical personnel; c) travel to research meetings or training; (d) statistical services including personnel and computer time.

3. Ancillary Personnel Support: Salary for secretaries and administrative assistants is not allowed. Support for mentors is not allowed.

4. Facilities and Administrative Costs: NIA and ODS will reimburse these costs at 8 percent of modified total direct costs. The participating foundations do not pay facilities and administrative costs.

Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation, see NOT-OD-05-004.

Section III. Eligibility Information

1. Eligible Applicants

1.A. Eligible Institutions

You may submit (an) application(s) if your organization has any of the following characteristics:

The following organizations/institutions are eligible to apply:

Foreign organizations are not eligible to apply.

1.B. Eligible Individuals

If you have the skills, knowledge, and resources necessary to carry out the proposed research then you are invited to work with your institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. However, for the BCDA program, the following additional eligibility requirements apply to individuals who seek to become BCDA recipients (Principal Investigators).

You must have a clinical doctoral degree (e.g., MD, DO, DDS) or its equivalent. Note that individuals with a doctoral degree that require a dissertation or thesis may apply for the BCDA program. These may include individuals holding both MD and PhD degrees as well as individuals with PhDs in clinical fields (such as clinical psychology, nursing, or physical therapy). However, such individuals are not eligible for a competing renewal of the BCDA.

For the K23 mechanism, in addition, you must have completed your clinical training, including specialty and, if applicable, subspecialty training prior to receiving an award. However, you may submit an application prior to completing clinical training. For either the K23 or K08 mechanism you must identify a mentor with extensive research experience, and you must be willing to spend a minimum of 75 percent (nine person-months) of full-time professional effort conducting research career development and research on aging.

At the time of award, you must have a full-time appointment at the academic institution that is the applicant institution. Candidates who have VA appointments may not consider part of the VA effort toward satisfying the full-time requirement at the applicant institution. In addition, you must be a citizen or noncitizen national of the United States, or have been lawfully admitted to the United States for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card I-551, or other legal verification of such status). Noncitizen nationals are generally persons born in outlying possessions of the United States (i.e., American Samoa and Swains Island). Individuals on temporary or student visas are not eligible. If you have questions concerning your eligibility you may seek advice from the Agency Contacts listed in Section VII.

Ineligible individuals include current and former principal investigators on NIH research project (R01), FIRST Awards (R29), sub- projects of program project (P01) or center grants (P50). Former mentored career awardees (K01, K08, K22, K23, K25) are also not eligible for these awards. Some current mentored career award holders are eligible for these awards. See Section III.3. Other Special Eligibility Criteria for further details. Principal investigators of NIH Small Grants (R03) or Exploratory/Developmental Grants (R21) remain eligible.

We strongly encourage you to apply for independent research grant support (such as an R01 or similar award) during the period of this award to maximize your chances of obtaining uninterrupted funding as you transition to full independence.

2. Cost Sharing or Matching

This program does not require cost-sharing as defined in the NIH Grants Policy Statement.

The most current Grants Policy Statement can be found at:

3. Other-Special Eligibility Criteria

Section IV. Application and Submission Information

1. Address to Request Application Information

The PHS 398 application instructions are available at in an interactive format. Applicants must use the currently approved version of the PHS 398. For further assistance contact GrantsInfo, Telephone (301) 710-0267, Email:

Telecommunications for the hearing impaired: TTY 301-451-5936.

2. Content and Form of Application Submission

Applications must be prepared using the most current PHS 398 research grant application instructions and forms. Applications must have a D&B Data Universal Numbering System (DUNS) number as the universal identifier when applying for Federal grants or cooperative agreements. The D&B number can be obtained by calling (866) 705-5711 or through the web site at The D&B number should be entered on line 11 of the face page of the PHS 398 form.

See also Section VI.2 for additional information.

The title and number of this funding opportunity must be typed in item (box) 2 only of the face page of the application form and the YES box must be checked.

SUPPLEMENTARY INSTRUCTIONS for Career Development awards are located in the PHS 398, Part 1, Section 7, starting on page I-53.

Note that applications responding to this announcement (new and resubmission) must include at least three sealed letters of reference attached to the face page of the original application. Applications submitted without the required number of reference letters will be considered incomplete and will be returned without review.

If you intend to resubmit as a response to this FOA an unfunded application that you submitted in response to RFA AG 07- 001 or to RFA AG 08-006, prior solicitations for the BCDA, then follow the instructions in the PHS 398 form for preparing resubmissions.

3. Submission Dates and Times

Applications must be received on or before the receipt date described below (Section IV.3.A). Submission times N/A.

3.A. Receipt, Review and Anticipated Start Dates
Letters of Intent Receipt Date: October 3, 2008
Application Receipt Date: November 3, 2008
Peer Review Date: February 2009
Council Review Date: May 2009
Earliest Anticipated Start Date: July 1, 2009

3.A.1. Letter of Intent

Prospective applicants are asked to submit a letter of intent that includes the following information:

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows NIA staff to estimate the potential review workload and plan the review.

The letter of intent is to be sent by the date listed at the beginning of this document.

The letter of intent should be sent to:

Robin A. Barr, D. Phil.
Office of Extramural Activities
National Institute on Aging
7201 Wisconsin Avenue, Room 2C218, MSC 9205
Bethesda, MD 20892-9205
Telephone: (301) 496-9322
FAX: (301) 402-2945

3.B. Sending an Application to the NIH

Applications must be prepared using the research grant applications found in the PHS 398 instructions for preparing a research career development award (CDA) application. Submit a signed, typewritten original of the application, including the checklist, and three signed photocopies in one package to:

Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express or regular mail)
Bethesda, MD 20817 (for express/courier service; non-USPS service)

Personal deliveries of applications are no longer permitted (see

At the time of submission, two additional copies of the application and all copies of the appendix material must be sent to:

Ramesh Vemuri, Ph.D., Chief
Scientific Review Branch
National Institute on Aging
Gateway Building, Room 2C212
Bethesda, MD 20892-9205
Telephone: (301) 496-9666
FAX: (301)402-0066

3.C. Application Processing

Applications must be received on or before the application receipt date(s) described above (Section IV.3.A.). If an application is received after that date, it will be returned to the applicant without review. Upon receipt, applications will be evaluated for completeness by the CSR and responsiveness by the NIA. Incomplete and non-responsive applications will not be reviewed.

The NIH will not accept any application in response to this funding opportunity that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. However, applications submitted in response to the prior Beeson solicitations, AG 07-001, and AG 08-006, but unfunded may be resubmitted to the current solicitation. Follow instructions in the PHS 398 form for preparing resubmissions. Other previously unfunded applications, originally submitted as an investigator-initiated application, that are to be submitted in response to this funding opportunity, should be prepared as NEW applications. That is, the application for this funding opportunity must not include an Introduction describing the changes and improvements made, and the text must not be marked to indicate the changes from the previous unfunded version of the application

Information on the status of an application should be checked by the Principal Investigator in the eRA Commons at:

4. Intergovernmental Review

This initiative is not subject to intergovernmental review.

5. Funding Restrictions

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The Grants Policy Statement can be found at

Pre-award costs are allowable. A grantee may, at its own risk and without NIH prior approval, incur obligations and expenditures to cover costs up to 90 days before the beginning date of the initial budget period of a new or renewal award if such costs: are necessary to conduct the project, and would be allowable under the grant, if awarded, without NIH prior approval. If specific expenditures would otherwise require prior approval, the grantee must obtain NIH approval before incurring the cost. NIH prior approval is required for any costs to be incurred more than 90 days before the beginning date of the initial budget period of a new or competing renewal award.

The incurrence of pre-award costs in anticipation of a competing or non-competing award imposes no obligation on NIH either to make the award or to increase the amount of the approved budget if an award is made for less than the amount anticipated and is inadequate to cover the pre-award costs incurred. NIH expects the grantee to be fully aware that pre-award costs result in borrowing against future support and that such borrowing must not impair the grantee's ability to accomplish the project objectives in the approved time frame or in any way adversely affect the conduct of the project. See NIH Grants Policy Statement

6. Other Submission Requirements and Information

The principal investigator and the primary mentor should commit to attending one annual meeting a year as a condition of accepting a BCDA. You should budget funds for your individual travel to and from the annual Beeson meeting for one meeting a year. (The location of the meeting will vary from year to year.)

As part of a cover letter submitted with the application please indicate whether you will submit your application and the written results of the review (the summary statement) to the American Federation for Aging Research (see Section 2, ii, Funds Available). The cover letter should be signed by the institutional official who signs the face page of the application.

In addition to the Supplementary Instructions in the PHS 398 for Research Career Awards (Instructions, Part III, starting on page 51), the following information must be included in the application:


The BCDA program seeks to develop independent investigators and future leaders in the fields of aging research. Describe your commitment to an academic career in clinically-relevant research on aging. Include a description of your professional responsibilities in the grantee institution and elsewhere and show their relation to the proposed activities on the career award:

Statement(s) by Mentors(s)/Consultant(s)/Collaborator(s)

Consultant(s)/Collaborator(s): Signed statements must be provided by each consultant/collaborator confirming their participation in the project and describing their specific roles. Collaborators and consultants generally do not need to provide their biosketches. However, information should be provided clearly documenting the appropriate expertise in the proposed areas of consulting/collaboration.

Environment and Institutional Commitment to the Candidate

The sponsoring institution must define and document a strong, well-established research and training program related to your area of interest including a high-quality research environment with staff capable of collaborating with you productively. The sponsoring institution must commit to assisting your development into a productive, independent investigator and to meeting the requirements of this award. It should be clear that the institutional commitment to you is not contingent upon receipt of the BCDA award.

A letter from a responsible official (department chair or academic dean) at your sponsoring institution should:

Candidates who will be using the resources within a General Clinical Research Center (GCRC) or Clinical and Translational Science Award (CTSA) during the course of the award are requested to include a letter of agreement from either the GCRC/CTSA program director or the principal investigator with the application.

Career Development Plan

Describe any professional responsibilities/activities (including other research projects and clinical responsibilities) beyond the effort devoted to the BCDA award. Explain how these responsibilities/activities will help ensure that you become an independent investigator in clinically-relevant aging research. Describe any opportunities for leadership that these responsibilities allow.

Training in the Responsible Conduct of Research

You must describe a program to provide formal or informal instruction in scientific integrity or the responsible conduct of research. Applications without plans for instructions in the responsible conduct of research will be considered incomplete and may be returned to you without review. Although the NIH does not establish specific curricula or formal requirements, all programs are encouraged to consider instruction in the following areas: conflict of interest, responsible authorship, policies for handling misconduct, policies regard the use of human and animal subjects, and data management. Applicants must follow the application instructions found on page 56 of the PHS-398 application package and refer to the NIH web site ( for additional guidance.

Document prior instruction in, or propose plans for instruction in, the responsible conduct of research in terms of subject matter and duration of instruction. An award cannot be made if an application lacks this component.

Research Plan

Letters of Reference

Include three sealed letters of reference from well-established scientists with the application addressing the above areas and any other evidence that you have a high potential for becoming an independent investigator and future leader in clinically relevant aging research. The primary mentor's letter of support will be considered independently of the three letters of reference. All unopened letters of reference should be attached to the front page of the application.

Budget for the Entire Proposed Period of Support

The total direct costs requested must be consistent with the amounts described under Funds Available, Section II.2.

Appendix Materials

All paper PHS 398 applications submitted must provide appendix material on CDs only. Include five identical CDs in the same package with the application. (See

Do not use the Appendix to circumvent the page limitations of the Research Plan component. An application that does not observe the required page limitations may be delayed in the review process.

Resource Sharing Plan(s)

NIH considers the sharing of unique research resources developed through NIH-sponsored research an important means to enhance the value of, and advance research. When resources have been developed with NIH funds and the associated research findings published or provided to NIH, it is important that they be made readily available for research purposes to qualified individuals within the scientific community. If the final data/resources are not amenable to sharing, this must be explained in Resource Sharing section of the application. See

(a) Data Sharing Plan: Not Applicable

(b) Sharing Model Organisms: Regardless of the amount requested, all applications where the development of model organisms is anticipated are expected to include a description of a specific plan for sharing and distributing unique model organisms and related resources, or state appropriate reasons why such sharing is restricted or not possible. See Sharing Model Organisms Policy, and NIH Guide NOT-OD-04-042.

(c) Genome-Wide Association Studies (GWAS): Regardless of the amount requested, applicants seeking funding for a genome-wide association study are expected to provide a plan for submission of GWAS data to the NIH-designated GWAS data repository, or provide an appropriate explanation why submission to the repository is not possible. A genome-wide association study is defined as any study of genetic variation across the entire genome that is designed to identify genetic associations with observable traits (such as blood pressure or weight) or the presence or absence of a disease or condition. For further information see Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies, NIH Guide NOT-OD-07-088, and

Section V. Application Review Information

1. Criteria

The following will be considered in making funding decisions:

2. Review and Selection Process

Applications that are complete and responsive to the FOA will be evaluated for scientific and technical merit by an appropriate peer review group convened by NIA in accordance with the review criteria stated below.

As part of the initial merit review, all applications will:

The goals of NIH-supported career development programs are to help ensure that diverse pools of highly trained scientists are available in adequate numbers and in appropriate research areas to address the Nation’s biomedical, behavioral, and clinical research needs. The scientific review group will address and consider the investigators (candidate, mentor); the approach (research plan, career plan); the significance (research plan); the environment (institutional environment and commitment to candidate); and innovation (research plan) in assigning the application’s overall score, weighting them as appropriate for each application. Note, however that a mentored career development application does not need to be strong in all categories to be judged as highly meritorious and thus deserve a favorable priority score. For example, an applicant may propose to carry out important work that by its nature is not innovative but is essential to move a field forward, and will provide a strong vehicle for his/her career development and progression to independence. Within the context of the above review criteria, each application will be evaluated for the following elements:

The application does not need to be strong in all categories to deserve a high priority score. These criteria are listed in logical order and not in order of priority.


Mentor(s), Consultant(s), Collaborator(s)

Research Plan

Career Development Plan

Environment and Institutional Commitment to the Candidate

2.A. Special Review Criteria

The following special review criteria are important components of a career development award and will be considered in the determination of scientific merit and the priority score:

Training in the responsible conduct of research: Does the application include appropriate and adequate training in the responsible conduct of research?

Mentor(s) statement(s) and letters of reference: Do(es) the mentor(s) adequately address the above review criteria including the candidate’s potential and his/her strengths and areas needing improvement? In addition, do the letters of reference from at least three well-established scientists address the above review criteria, and do they demonstrate evidence that the candidate has a high potential for becoming an independent investigator?

Plans to Evaluate Progress: Are there adequate plans for monitoring and evaluating the career development awardee’s progress toward independence?

2.B. Additional Review Considerations

Budget: The reasonableness of the proposed budget and the requested period of support in relation to the proposed research career development program. The priority score should not be affected by the evaluation of the budget.

2.C. Resource Sharing Plan(s)

When relevant, reviewers will be instructed to comment on the reasonableness of the following Resource Sharing Plans, or the rationale for not sharing the following types of resources. However, reviewers will not factor the proposed resource sharing plan(s) into the determination of scientific merit or priority score, unless noted otherwise in the FOA. Program staff within NIA will be responsible for monitoring the resource sharing.

3. Anticipated Announcement and Award Dates

Not applicable

Section VI. Award Administration Information

1. Award Notices

After the peer review of the application is completed, the Principal Investigator will be able to access the Summary Statement (written critique) via the NIH eRA Commons.

If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant. For details, applicants may refer to the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General (

A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. The NoA signed by the grants management officer is the authorizing document. Once all administrative and programmatic issues have been resolved, the NoA will be generated via email notification from the awarding component to the grantee business official.

Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs. See Also Section IV.5. Funding Restrictions.

2. Administrative and National Policy Requirements

All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General ( and Part II Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities (

The following related administrative policies apply to these BCDA K08 and K23 awards.

A. Evaluation

In carrying out their stewardship of human resource related programs, NIA, or ODS, may request information essential to assess the effectiveness of this program. Accordingly, you are hereby notified that you may be contacted after the completion of this award for periodic updates on various aspects of your employment history, publications, support from research grants or contracts, honors and awards, professional activities, and other information helpful in evaluating the impact of the program.

B. Other Income

Awardees may retain royalties and fees for activities such as scholarly writing, service on advisory groups, honoraria from other institutions for lectures or seminars, fees resulting from clinical practice, professional consultation or other comparable activities, provided these activities remain incidental, are not required by the research and research-related activities of this award, and provided that the retention of such pay is consistent with the policies and practices of the grantee institution.

All other income and fees, not included in the preceding paragraph as retainable, may not be retained by the career award recipient. Such fees must be assigned to the grantee institution for disposition by any of the following methods:

C. Special Leave

Leave to another institution, including a foreign laboratory may be permitted if the experience that you propose is directly related to the purpose of your award. Only local, institutional approval is required if such leave does not exceed 3 months. For longer periods, prior written approval of NIA is required. Details on the process for submission of prior approval requests can be founds in the NIHGPS (rev. 12/03), Requests for Prior Approval, at .

A copy of a letter or other evidence from the institution where the leave is to be taken must be submitted to assure that satisfactory arrangements have been made. Support from the BCDA award will continue during such leave.

Leave without award support may not exceed 12 months. Such leave requires the prior written approval of NIA and will be granted only in unusual situations. Support from other sources is permissible during the period of leave. Such leave does not reduce the total number of months of program support for which you are eligible.

Under unusual and pressing circumstances, you may submit a written request to NIA , requesting a reduction in professional effort below 75 percent (nine person-months). Such requests will be considered on a case-by-case basis during the award period. In no case, will it be permissible to work at a rate of less than 50 percent effort (six person-months). The nature of the circumstances requiring reduced effort might include medical conditions, disability, or pressing personal or family situations such as child or elder care. Permission to reduce the level of effort will not be approved to accommodate other sources of funding (except as described at:,job opportunities, clinical practice, or clinical training. In each situation, your grantee institution must submit documentation supporting the need for reduced effort along with assurance of a continuing commitment to your scientific development. Further, you must provide written assurance of your intent to return to full-time professional effort (at least 75 percent) as soon as possible. During the period of reduced effort, the salary and other costs supported by the award will be reduced accordingly.

D. Changes in Research or Career Development Program

Individual awards are made for career development at a specific institution in a specific research program. A change in the specified scientific area of the research component of the career development program requires prior approval of NIA. A scientific rationale must be provided for any proposed changes in the aims of the original peer-reviewed research plan. The new research plan will be evaluated by NIA staff to ensure that the plan remains within the scope of the original peer-reviewed research program. If the new plan does not satisfy this requirement, program staff could recommend that the award be terminated.

E. Termination or Change of Institution

When a grantee institution plans to terminate an award, the NIA must be notified in writing at the earliest possible time so that appropriate instructions can be given for termination. The Director of the NIA may discontinue an award upon determination that the purpose or terms of the award are not being fulfilled. In the event an award is terminated, the NIA, shall notify both you and your institution in writing of this determination, the reasons for it, the effective date, and the right to appeal the decision.

If you plan a change of institution, you must submit to NIA in advance of the change a written request for transfer, countersigned by the appropriate institutional business official, describing the reasons for the change and including the new sponsor's name and biosketch when applicable. You must establish in this request that the specific aims of the research program to be conducted at the new institution are within the scope of the original peer reviewed research program. Additionally, the new sponsor must have the appropriate research expertise to supervise the program and sufficient research support to ensure continuation of the research program to the end of the award (initial award). Staff at NIA will review this request and may require a review by an initial review group and/or the appropriate national advisory council or board. Upon approval of this request, a new BCDA application must be submitted by the new institution far enough in advance of the requested effective date to permit review. The period of support requested in the new application must be no more than the time remaining within the existing award period.

When a mentor at your grantee institution is to be replaced, the institution must submit a letter from the proposed mentor documenting the need for substitution, the new mentor's qualifications for supervising the program, and the level of support for your career development. The letter must also document that the specific aims of the research program will remain within the scope of the original peer reviewed research program. Staff within NIA will review the request, and will notify the grantee institution of the results of the evaluation.

A final progress report, invention statement, and Financial Status Report are required upon either termination of an award or when an institution relinquishes an award.

3. Reporting

Awardees will be required to submit the PHS Non-Competing Grant Progress Report, Form 2590 ( annually and financial statements as required in the NIH Grants Policy Statement. Note that the instructions for Research Career Development applications must be followed for this program.

Section VII. Agency Contacts

We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research, peer review, and financial or grants management issues:

1. Scientific/Research Contacts:

Robin A. Barr, D. Phil.
Office of Extramural Activities
National Institute on Aging
7201 Wisconsin Avenue, Room 2C218, MSC 9205
Bethesda, MD 20892-9205
Telephone: (301) 496-9322
FAX: (301) 402-2945

Mary Frances Picciano, Ph.D.
Senior Nutrition Research Scientist
Office of Dietary Supplements
National Institutes of Health
6100 Executive Blvd, 3B01
Bethesda, MD 20892-7517
Telephone: (301) 435-3608
FAX: (301) 480-1845

2. Peer Review Contacts:

Ramesh Vemuri, Ph.D.
Chief, Scientific Review Branch
National Institute on Aging
Gateway Building, Suite 2C212
Bethesda, MD 20892-2292
Telephone: (301) 496-9666
FAX: (301) 402-0066

3. Financial or Grants Management Contacts:

Linda Whipp
Grants Management Officer
National Institute on Aging
Gateway Building, Suite 2N212
Bethesda, MD 20892-2292
Telephone: (301) 496-1472
FAX: (301) 402-3672

Section VIII. Other Information

Required Federal Citations

Use of Animals in Research:
Recipients of PHS support for activities involving live, vertebrate animals must comply with PHS Policy on Humane Care and Use of Laboratory Animals ( as mandated by the Health Research Extension Act of 1985 (, and the USDA Animal Welfare Regulations ( as applicable.

Human Subjects Protection:
Federal regulations (45CFR46) require that applications and proposals involving human subjects must be evaluated with reference to the risks to the subjects, the adequacy of protection against these risks, the potential benefits of the research to the subjects and others, and the importance of the knowledge gained or to be gained (

Data and Safety Monitoring Plan:
Data and safety monitoring is required for all types of clinical trials, including physiologic toxicity and dose-finding studies (phase I); efficacy studies (Phase II); efficacy, effectiveness and comparative trials (Phase III). Monitoring should be commensurate with risk. The establishment of data and safety monitoring boards (DSMBs) is required for multi-site clinical trials involving interventions that entail potential risks to the participants (NIH Policy for Data and Safety Monitoring, NIH Guide for Grants and Contracts,

Access to Research Data through the Freedom of Information Act:
The Office of Management and Budget (OMB) Circular A-110 has been revised to provide access to research data through the Freedom of Information Act (FOIA) under some circumstances. Data that are (1) first produced in a project that is supported in whole or in part with Federal funds and (2) cited publicly and officially by a Federal agency in support of an action that has the force and effect of law (i.e., a regulation) may be accessed through FOIA. It is important for applicants to understand the basic scope of this amendment. NIH has provided guidance at Applicants may wish to place data collected under this funding opportunity in a public archive, which can provide protections for the data and manage the distribution for an indefinite period of time. If so, the application should include a description of the archiving plan in the study design and include information about this in the budget justification section of the application. In addition, applicants should think about how to structure informed consent statements and other human subjects procedures given the potential for wider use of data collected under this award.

Sharing of Model Organisms:
NIH is committed to support efforts that encourage sharing of important research resources including the sharing of model organisms for biomedical research (see At the same time the NIH recognizes the rights of grantees and contractors to elect and retain title to subject inventions developed with Federal funding pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement All investigators submitting an NIH application or contract proposal, beginning with the October 1, 2004 receipt date, are expected to include in the application/proposal a description of a specific plan for sharing and distributing unique model organism research resources generated using NIH funding or state why such sharing is restricted or not possible. This will permit other researchers to benefit from the resources developed with public funding. The inclusion of a model organism sharing plan is not subject to a cost threshold in any year and is expected to be included in all applications where the development of model organisms is anticipated.

Inclusion of Women And Minorities in Clinical Research:
It is the policy of the NIH that women and members of minority groups and their sub-populations must be included in all NIH-supported clinical research projects unless a clear and compelling justification is provided indicating that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All investigators proposing clinical research should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research (; a complete copy of the updated Guidelines is available at The amended policy incorporates: the use of an NIH definition of clinical research; updated racial and ethnic categories in compliance with the new OMB standards; clarification of language governing NIH-defined Phase III clinical trials consistent with the new PHS Form 398; and updated roles and responsibilities of NIH staff and the extramural community. The policy continues to require for all NIH-defined Phase III clinical trials that: a) all applications or proposals and/or protocols must provide a description of plans to conduct analyses, as appropriate, to address differences by sex/gender and/or racial/ethnic groups, including subgroups if applicable; and b) investigators must report annual accrual and progress in conducting analyses, as appropriate, by sex/gender and/or racial/ethnic group differences.

Required Education on the Protection of Human Subject Participants:
NIH policy requires education on the protection of human subject participants for all investigators submitting NIH applications for research involving human subjects and individuals designated as key personnel. The policy is available at

Human Embryonic Stem Cells (hESC):
Criteria for federal funding of research on hESCs can be found at and at Only research using hESC lines that are registered in the NIH Human Embryonic Stem Cell Registry will be eligible for Federal funding ( It is the responsibility of the applicant to provide in the project description and elsewhere in the application as appropriate, the official NIH identifier(s) for the hESC line(s)to be used in the proposed research. Applications that do not provide this information will be returned without review.

NIH Public Access Policy:
NIH-funded investigators are requested to submit to the NIH manuscript submission (NIHMS) system ( at PubMed Central (PMC) an electronic version of the author's final manuscript upon acceptance for publication, resulting from research supported in whole or in part with direct costs from NIH. The author's final manuscript is defined as the final version accepted for journal publication, and includes all modifications from the publishing peer review process.

NIH is requesting that authors submit manuscripts resulting from 1) currently funded NIH research projects or 2) previously supported NIH research projects if they are accepted for publication on or after May 2, 2005. The NIH Public Access Policy applies to all research grant and career development award mechanisms, cooperative agreements, contracts, Institutional and Individual Ruth L. Kirschstein National Research Service Awards, as well as NIH intramural research studies. The Policy applies to peer-reviewed, original research publications that have been supported in whole or in part with direct costs from NIH, but it does not apply to book chapters, editorials, reviews, or conference proceedings. Publications resulting from non-NIH-supported research projects should not be submitted.

For more information about the Policy or the submission process please visit the NIH Public Access Policy Web site at and view the Policy or other Resources and Tools including the Authors' Manual (

Standards for Privacy of Individually Identifiable Health Information:
The Department of Health and Human Services (DHHS) issued final modification to the "Standards for Privacy of Individually Identifiable Health Information", the "Privacy Rule", on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the DHHS Office for Civil Rights (OCR).

Decisions about applicability and implementation of the Privacy Rule reside with the researcher and his/her institution. The OCR website ( provides information on the Privacy Rule, including a complete Regulation Text and a set of decision tools on "Am I a covered entity?" Information on the impact of the HIPAA Privacy Rule on NIH processes involving the review, funding, and progress monitoring of grants, cooperative agreements, and research contracts can be found at

URLs in NIH Grant Applications or Appendices:
All applications and proposals for NIH funding must be self-contained within specified page limitations. For publications listed in the appendix and/or Progress report, internet addresses (URLs) must be used for publicly accessible on-line journal articles. Unless otherwise specified in this solicitation, Internet addresses (URLs) should not be used to provide any other information necessary for the review because reviewers are under no obligation to view the Internet sites. Furthermore, we caution reviewers that their anonymity may be compromised when they directly access an Internet site.

Healthy People 2010:
The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010," a PHS-led national activity for setting priority areas. This FOA is related to one or more of the priority areas. Potential applicants may obtain a copy of "Healthy People 2010" at

Authority and Regulations:
This program is described in the Catalog of Federal Domestic Assistance at and is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR 52 and 45 CFR Parts 74 and 92. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The NIH Grants Policy Statement can be found at

The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.

Loan Repayment Programs:
NIH encourages applications for educational loan repayment from qualified health professionals who have made a commitment to pursue a research career involving clinical, pediatric, contraception, infertility, and health disparities related areas. The LRP is an important component of NIH's efforts to recruit and retain the next generation of researchers by providing the means for developing a research career unfettered by the burden of student loan debt. Note that an NIH grant is not required for eligibility and concurrent career award and LRP applications are encouraged. The periods of career award and LRP award may overlap providing the LRP recipient with the required commitment of time and effort, as LRP awardees must commit at least 50% of their time (at least 20 hours per week based on a 40 hour week) for two years to the research. For further information, please see:

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy
NIH... Turning Discovery Into Health®

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.